Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|August 9, 2022
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative GroupSara Steffanoni, Teresa Calimeri, Alice Laurenge, et al.
Cancers|June 29, 2019
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12Francesco Autore, Paolo Strati, Idanna Innocenti, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2013
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOPAlexandar Tzankov, Zijun Y Xu-Monette, Marc Gerhard, et al.
Blood|June 3, 2011
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapySantiago Montes-Moreno, Nerea Martinez, Beatriz Sanchez-Espiridión, et al.
Leukemia|November 3, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trialMouhamad Khouja, Elisa Genuardi, Simone Ferrero, et al.
Molecular Cancer Research : MCR|November 6, 2020
Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted AgentsManman Deng, Zijun Y Xu-Monette, Lan V Pham, et al.
Oncotarget|May 29, 2018
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphomaAlessandro Broccoli, Beatrice Casadei, Alice Morigi, et al.
Blood Advances|July 30, 2020
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCLZijun Y Xu-Monette, Hongwei Zhang, Feng Zhu, et al.
Blood Advances|December 5, 2025
Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosisXue Kong, Zijun Y Xu-Monette, Zhenming Xu, et al.
Journal for Immunotherapy of Cancer|October 24, 2019
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapiesZijun Y Xu-Monette, Jianyong Li, Yi Xia, et al.
Pageof 17